Halozyme Therapeutics Inc... (HALO)
NASDAQ: HALO
· Real-Time Price · USD
67.28
1.74 (2.65%)
At close: Aug 15, 2025, 3:59 PM
67.45
0.25%
After-hours: Aug 15, 2025, 06:36 PM EDT
Halozyme Therapeutics Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | 557.28M | 485.36M | 444.09M | 392.47M | 337.29M | 318.8M | 281.59M | 253.91M | 233.71M | 181.64M | 202.13M | 211.2M | 366.15M | 434.92M | 402.71M | 409.1M | 228.72M | 163.08M |
Depreciation & Amortization | 81.73M | 81.59M | 81.34M | 81.62M | 84.34M | 84.61M | 84.86M | 71.28M | 77.4M | 69.32M | 49.64M | 43.3M | 14.85M | 3.04M | 3M | 3.02M | 3.08M | 3.17M |
Stock-Based Compensation | 46.87M | 44.18M | 43.38M | 41.59M | 38.38M | 38.53M | 36.62M | 34.18M | 31.61M | 27.62M | 24.4M | 22.3M | 20.9M | 20.64M | 20.82M | 19.89M | 18.71M | 17.6M |
Other Working Capital | 97.21M | 54.97M | 74.23M | -3.72M | -51.3M | -4.19M | -32.61M | -57K | 5.3M | 6.29M | 2.06M | -11.09M | -9.24M | -11.76M | -4.93M | 42.03M | 517.14M | 988.09M |
Other Non-Cash Items | -84.58M | 89.92M | 141.42M | 145.2M | 132.47M | 40.32M | -10.33M | -12.8M | 6.76M | 10.22M | 9.89M | 10.1M | 4.48M | 2.5M | 23.09M | 29.77M | 32.77M | 32.45M |
Deferred Income Tax | -24.95M | -3.62M | 532K | 25.25M | 34.66M | 31.92M | 34.51M | 39.76M | 55.76M | 30.95M | 40.01M | 12.38M | -155.23M | -141.34M | -153.92M | -140.69M | 1.99M | 1.58M |
Change in Working Capital | -28.57M | -103.36M | -89.28M | -140.74M | -64.72M | -30.93M | -38.67M | -17.65M | -99.34M | -40.47M | -85.95M | -59.1M | 41.13M | -30.82M | 3.74M | -53.25M | -133.08M | -99.29M |
Operating Cash Flow | 547.77M | 503.86M | 479.06M | 402.95M | 419.99M | 431.03M | 388.57M | 368.67M | 305.89M | 279.28M | 240.11M | 240.17M | 292.28M | 288.94M | 299.44M | 267.84M | 152.19M | 118.59M |
Capital Expenditures | -7.08M | -8.1M | -10.7M | -10.24M | -11.67M | -7.46M | -15.29M | -15.04M | -13.11M | -15.7M | -4.81M | -2.62M | -2.11M | -1.68M | -1.46M | -3M | -2.68M | -2.66M |
Cash Acquisitions | n/a | n/a | n/a | 5.7M | 86.2M | 86.2M | 134.99M | 139.28M | 58.77M | -940.35M | -989.13M | -999.12M | -999.12M | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -597.82M | -588.48M | -647.6M | -617.45M | -475.18M | -381.75M | -292.91M | -301.14M | -139.44M | -180.31M | -255.21M | -594.85M | -636.28M | -716.35M | -652.51M | -348.05M | -389.87M | -283.91M |
Sales Maturities Of Investments | 461.26M | 326.11M | 395.57M | 327.2M | 270.38M | 269.79M | 211.3M | 215.83M | 134.64M | 671.26M | 746.13M | 795.85M | 820.82M | 307.68M | 247.68M | 302.45M | 330.69M | 281.23M |
Other Investing Acitivies | n/a | -39.46M | -118.59M | -124.29M | -204.79M | -111.97M | -81.61M | -65.94M | 14.57M | -22.78M | -22.81M | -332.11M | -348.56M | -408.67M | -404.83M | -105.31M | -88.72M | -32.23M |
Investing Cash Flow | -143.64M | -270.46M | -262.72M | -300.49M | -216.46M | -119.43M | -96.91M | -90.36M | -7.92M | -497.86M | -487M | -784.73M | -800.67M | -410.34M | -406.29M | -48.38M | -61.52M | -5M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | -13.48M | -13.48M | 171.48M | 535.48M | 548.96M | 548.96M | 364M | n/a | 415.81M | 415.81M | 415.81M | 412.95M |
Common Stock Repurchased | -553.49M | -250M | -250.49M | -252.79M | -252.79M | -251.74M | -401.33M | -149.04M | -349.04M | -350.08M | -200M | -360.32M | -225.04M | -273.88M | -350.06M | -229.88M | -221.57M | -174.72M |
Dividend Paid | n/a | n/a | n/a | -13.48M | -13.48M | -13.48M | -13.48M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -43.83M | -43.83M | -43.83M |
Other Financial Acitivies | 3.58M | 9.75M | 12.58M | 11.37M | 15.47M | 8.44M | 7.88M | 11.83M | 10.36M | 11.74M | 13.41M | 11.39M | 13.4M | 13.06M | 12.11M | 20.55M | 28.45M | 43.41M |
Financial Cash Flow | -530.14M | -221.69M | -218.86M | -222.37M | -236.83M | -243.86M | -407.99M | -151.74M | -168.24M | 197.13M | 362.37M | 200.03M | 152.36M | -260.21M | 77.86M | 206.48M | 222.69M | 281.04M |
Net Cash Flow | -126M | 11.7M | -2.52M | -119.91M | -33.3M | 67.74M | -116.33M | 126.57M | 129.73M | -21.45M | 115.48M | -344.52M | -356.03M | -381.62M | -28.98M | 425.94M | 313.36M | 394.63M |
Free Cash Flow | 540.69M | 495.76M | 468.37M | 392.71M | 408.32M | 423.57M | 373.28M | 353.63M | 292.79M | 263.58M | 235.3M | 237.55M | 290.17M | 287.26M | 297.98M | 264.85M | 149.51M | 115.93M |